Cart
sales@molnova.com
Citiolase
CAS No. 1195-16-0
Citiolase( Citiolone | Thioxidrene )
Catalog No. M23366 CAS No. 1195-16-0
Citiolone is a thiolic-derived medication as a mucolytic agent for the treatment of certain hepatic disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 31 | In Stock |
|
| 500MG | 47 | In Stock |
|
| 1G | 55 | In Stock |
|
Biological Information
-
Product NameCitiolase
-
NoteResearch use only, not for human use.
-
Brief DescriptionCitiolone is a thiolic-derived medication as a mucolytic agent for the treatment of certain hepatic disorders.
-
DescriptionCitiolone is a thiolic-derived medication as a mucolytic agent for the treatment of certain hepatic disorders.
-
In Vitro——
-
In Vivo——
-
SynonymsCitiolone | Thioxidrene
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1195-16-0
-
Formula Weight159.21
-
Molecular FormulaC6H9NO2S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 35 mg/mL?(219.84mM)
-
SMILESCC(NC(CCS1)C1=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Poletti T , Bertola D . [Citiolone in the treatment of liver cirrhosis][J]. Minerva Gastroenterologica, 1977, 23(1):11.
molnova catalog
related products
-
Cyclic MKEY TFA (934...
Cyclic MKEY TFA is a synthetic cyclic peptide inhibitor of CXCL4-CCL5 heterodimer formation, which protects against atherosclerosis and aortic aneurysm formation by mediating inflammation.
-
Cuscutamine
Cuscutamine has luciferase-inducing activity and can significantly stimulate cancer cell proliferation.
-
SBE 13 hydrochloride
SBE13 hydrochloride is an effective and specific PLK1 inhibitor (IC50: 0.2 nM); no inhibition om Aurora A kinase, Plk2/3.
